4D Molecular Therapeutics Inc.
FDMT | NASDAQ
$15.93
+$0.69 (+4.53%)
Sep 22, 2026, 12:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -72.94M | -68.76M | 19.4M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M | -28.68M | -27.38M | -25.69M | -28.09M | -26.34M | -25.08M | -22.24M | -7.59M | -16.41M |
Depreciation & Amortization | 494K | 2.06M | 1.98M | 2M | 1.89M | 1.75M | 1.78M | 1.7M | 1.62M | 1.59M | 1.51M | 1.4M | 1.43M | 1.41M | 1.39M | 879K | 831K | 782K | 1.89M | 760K | 742K | 748K |
Stock-Based Compensation | 5.88M | 4.45M | 5.55M | 4.52M | 4.96M | 6.99M | 7.58M | 6.49M | 6.07M | 5.97M | 5.91M | 4.56M | 4.97M | 4.22M | 4.35M | 4.52M | 4.32M | 3.93M | 3.73M | 3.92M | 3.82M | 2.33M |
Other Working Capital | 480K | -8.28M | -1.54M | 6.84M | 1.04M | -6.94M | -5.18M | 8.97M | 98K | -4.22M | 1.75M | 1.73M | 412K | -4.16M | -1.87M | 720K | 2.31M | -905K | -5.52M | 582K | -13.37M | -2.08M |
Other Non-Cash Items | 137K | -1.12M | -1.13M | -1.14M | -1.15M | -1.36M | -1.84M | -2.2M | -2.3M | -735K | 173K | 29K | -205K | -366K | -211K | 252K | 492K | 611K | 738K | 31K | 15K | 114K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -630K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.58M | -4.75M | 2.76M | 5M | 5.59M | -7.17M | -3.72M | 8.46M | -688K | -3.52M | 664K | 3.1M | 1.36M | -4.49M | -358K | -977K | 2.54M | -2.54M | -3.11M | 1.8M | -13.19M | -2.16M |
Operating Cash Flow | -70M | -68.13M | 28.55M | -46.5M | -43.38M | -47.76M | -45.86M | -29.39M | -30.24M | -29.09M | -24.65M | -1.17M | -22.07M | -27.91M | -22.21M | -21.02M | -19.9M | -23.55M | -21.84M | -15.72M | -16.21M | -15.37M |
Capital Expenditures | -55K | n/a | -631K | 91K | -66K | -631K | -949K | -1.78M | -349K | -710K | -549K | -405K | -805K | -1.01M | -1.09M | -1.96M | -2.07M | -6.41M | -5.1M | -2.64M | -737K | -642K |
Cash Acquisitions | n/a | 11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49.08M | n/a | -50.09M | 1.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -62.04M | -33.52M | -178.1M | -15.24M | -115.4M | -134.08M | -57.78M | -35.79M | -96.76M | -277.32M | -34.65M | n/a | -5.43M | -14.73M | 100.51M | -187.94M | -6.19M | -59.69M | -32.2M | -136.38M | n/a | n/a |
Sales Maturities Of Investments | 87.65M | 102.4M | 49.18M | 32.93M | 101.62M | 166.66M | 65.79M | 64.87M | 23.57M | 14.78M | 28.51M | 30.39M | 55.52M | 58.87M | -135.19M | 205.28M | 65.72M | 12M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -11K | -11K | 767K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.08M | n/a | 50.09M | -1.01M | n/a | n/a | n/a | n/a | 5M | n/a | n/a | n/a |
Investing Cash Flow | 25.54M | 68.89M | -128.85M | 17.78M | -13.85M | 31.95M | 7.06M | 27.3M | -73.54M | -263.26M | -6.68M | 29.98M | 49.29M | 43.13M | -35.78M | 15.37M | 57.47M | -54.11M | -32.29M | -139.01M | -737K | -642K |
Debt Repayment | 19.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 567K | 1.56M | 3.11M | 4.76M | 1.58M | 799K | 1.35M | n/a | n/a | n/a | n/a | 116.14M | n/a | n/a | -847K |
Financial Cash Flow | 42.34M | 11.48M | 111.98M | 116K | 862K | n/a | 601K | 568K | 17.25M | 318.83M | 4.76M | 10.56M | 130.52M | 10.99M | 2.05M | 460K | -50K | 629K | 116.14M | 1.98M | 820K | -847K |
Net Cash Flow | -2.12M | 12.25M | 11.69M | -28.6M | -63.81M | -15.81M | -38.2M | -1.52M | -86.53M | 26.49M | -26.57M | 39.37M | 157.74M | 26.22M | -55.95M | -5.19M | 37.51M | -77.03M | 62.01M | -152.75M | -16.12M | -16.86M |
Free Cash Flow | -70.05M | -68.13M | 27.92M | -46.41M | -43.44M | -48.39M | -46.81M | -31.17M | -30.59M | -29.8M | -25.2M | -1.58M | -22.87M | -28.92M | -23.31M | -22.98M | -21.97M | -29.96M | -26.93M | -18.36M | -16.94M | -16.01M |
Adj. Free Cash Flow | -75.94M | -72.58M | 22.37M | -50.93M | -48.4M | -55.38M | -54.39M | -37.66M | -36.67M | -35.77M | -31.11M | -6.14M | -27.84M | -33.14M | -27.65M | -27.5M | -26.29M | -33.9M | -30.66M | -22.28M | -20.76M | -18.34M |
Maintenance CapEx | -55K | n/a | n/a | 182K | -53.84K | -631K | -910.08K | -1.78M | -349K | -710K | -549K | n/a | -701.03K | -1.01M | n/a | -1.96M | -2.07M | -6.41M | -4.29M | -2.64M | n/a | -642K |
Growth CapEx | n/a | n/a | -631K | -91K | -12.16K | n/a | -38.92K | n/a | n/a | n/a | n/a | -405K | -103.97K | n/a | -1.09M | n/a | n/a | n/a | -808.07K | n/a | -737K | n/a |
Owner Earnings | -70.05M | -68.13M | 28.55M | -46.32M | -43.43M | -48.39M | -46.77M | -31.17M | -30.59M | -29.8M | -25.2M | -1.17M | -22.77M | -28.92M | -22.21M | -22.98M | -21.97M | -29.96M | -26.12M | -18.36M | -16.21M | -16.01M |
Add to Watchlist
Select watchlists to add or remove FDMT